Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
V.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.149NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.413NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.9.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.107NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.10 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.41 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.71NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.142NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.166NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.11 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.34.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
W.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.250NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
B.1.1.130NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.311NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.93NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.104NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.177.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.225NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.309NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.105NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.307NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.171NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.57NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.67NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.279NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used